- Home
- BEEM vs PDSB Comparison
BEEM vs PDSB Comparison
Compare BEEM & PDSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BEEM
- PDSB
- Stock Information
- Founded
- BEEM 2006
- PDSB 2005
- Country
- BEEM United States
- PDSB United States
- Employees
- BEEM N/A
- PDSB N/A
- Industry
- BEEM Semiconductors
- PDSB Biotechnology: Pharmaceutical Preparations
- Sector
- BEEM Technology
- PDSB Health Care
- Exchange
- BEEM Nasdaq
- PDSB Nasdaq
- Market Cap
- BEEM 48.4M
- PDSB 48.0M
- IPO Year
- BEEM N/A
- PDSB N/A
- Fundamental
- Price
- BEEM $2.98
- PDSB $1.02
- Analyst Decision
- BEEM Strong Buy
- PDSB Strong Buy
- Analyst Count
- BEEM 4
- PDSB 2
- Target Price
- BEEM $5.33
- PDSB $10.00
- AVG Volume (30 Days)
- BEEM 2.0M
- PDSB 477.6K
- Earning Date
- BEEM 11-13-2025
- PDSB 11-13-2025
- Dividend Yield
- BEEM N/A
- PDSB N/A
- EPS Growth
- BEEM N/A
- PDSB N/A
- EPS
- BEEM N/A
- PDSB N/A
- Revenue
- BEEM $33,362,000.00
- PDSB N/A
- Revenue This Year
- BEEM N/A
- PDSB N/A
- Revenue Next Year
- BEEM $45.38
- PDSB N/A
- P/E Ratio
- BEEM N/A
- PDSB N/A
- Revenue Growth
- BEEM N/A
- PDSB N/A
- 52 Week Low
- BEEM $1.33
- PDSB $0.85
- 52 Week High
- BEEM $5.31
- PDSB $4.29
- Technical
- Relative Strength Index (RSI)
- BEEM 59.19
- PDSB 36.25
- Support Level
- BEEM $2.82
- PDSB $1.00
- Resistance Level
- BEEM $2.96
- PDSB $1.22
- Average True Range (ATR)
- BEEM 0.24
- PDSB 0.05
- MACD
- BEEM 0.02
- PDSB -0.01
- Stochastic Oscillator
- BEEM 71.08
- PDSB 9.09
About BEEM Beam Global
Beam Global produces sustainable technology for electric vehicle (EV) charging, outdoor media, and energy security, without the construction, disruption, and costs of grid-tied solutions. Its products are founded upon its patented EV ARC and Solar Treelines and include BeamTrak patented solar tracking, and ARC Technology energy storage, along with EV charging, outdoor media, and disaster preparedness packages. From start to finish, the company develops, patents, designs, engineers, and manufactures renewably energized products that help the environment, empower communities, and keep people moving.
About PDSB PDS Biotechnology Corporation
PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.